A Glimpse of the Holy Grail for Healthcare Cost Transparency
Michael Rea, PharmD, Founder & CEO at Rx Savings Solutions Imagine being told which car or computer you must buy and just forking over whatever […]
Michael Rea, PharmD, Founder & CEO at Rx Savings Solutions Imagine being told which car or computer you must buy and just forking over whatever […]
Illumina’s attempt to prevent the European Commission from carrying out an antitrust review of its $8 billion takeover last year of cancer diagnosis firm Grail […]
What You Should Know: – Ribbon Health, an API data platform for the healthcare industry that powers care decisions, and Turquoise Health, a provider of […]
Grail, a company focused on early cancer detection, introduced its test that screens for more than 50 kinds of cancer last year. At AWS’ Thursday […]
An NHS study of a new cancer blood test holds huge promise, but will not be without its challenges, says Snedden Campbell’s Ivor Campbell. The […]
A blood test called Galleri that could detect dozens of different forms of cancer before symptoms appear will start trials by the NHS in England […]
In closing its Grail acquisition before U.S. and European regulators sign off, Illumina is taking a chance the deal will pass regulatory muster. It’s a […]
The Federal Trade Commission and the European Union are reviewing the soundness of this acquisition. But if Illumina acquires Grail, the company that it spawned […]
The Federal Trade Commission is opposing Illumina’s proposed $7.1 billion Grail acquisition, arguing that it will reduce competition for multi-cancer early detection tests. Illumina disagrees […]
What You Should Know: – Emergency doctors in the UK have said many electronic health records (EHRs) in use are close to being unacceptable, and […]
What You Should Know: – DTx and Patient Support leaders, Amalgam Rx, Inc., announce the acquisition of Avhana Health, a privately-held clinical decision support (CDS) […]
Following years of research and investment, liquid biopsies are steadily accumulating FDA approvals. The tests are being used in molecular profiling of solid tumors and […]
Copyright © 2024 | WordPress Theme by MH Themes